,X,FilingDate,TradeDate,Ticker,InsiderName,Title,TradeType,Price,Qty,Owned,delta_Own,Value,1d,1w,1m,6m,ticker
0,,2020-03-18 18:00:53,2020-03-17,RARX,Ricardo Alonso,See Remarks,S - Sale,44.25,-2288,0,-100%,-101244.0,,,,,RARX
1,D,2020-03-18 18:00:26,2020-03-16,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
2,D,2020-03-18 18:00:26,2020-03-16,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,45.16,-10595,7132,-60%,-478521.0,,,,,RARX
3,D,2020-02-20 18:52:49,2020-02-18,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
4,D,2020-02-20 18:52:49,2020-02-18,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,46.61,-10595,7132,-60%,-493850.0,,,,,RARX
5,,2020-01-21 18:32:03,2020-01-17,RARX,Ricardo Alonso,See Remarks,S - Sale,47.02,-2285,2288,-50%,-107441.0,,,,,RARX
6,D,2020-01-16 18:01:59,2020-01-15,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
7,D,2020-01-16 18:01:59,2020-01-15,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,46.95,-10595,7132,-60%,-497441.0,,,,,RARX
8,,2019-12-18 18:01:44,2019-12-17,RARX,Ricardo Alonso,See Remarks,S - Sale,47.08,-2285,4573,-33%,-107568.0,,,,,RARX
9,D,2019-12-18 18:01:13,2019-12-17,RARX,Read Simon,Chief Scientific Officer,M - OptEx,2.87,10000,6234,-266%,28700.0,,,,,RARX
10,D,2019-12-18 18:01:13,2019-12-17,RARX,Read Simon,Chief Scientific Officer,S - Sale+OE,47.08,-10000,6234,-62%,-470821.0,,,,,RARX
11,D,2019-12-18 18:00:44,2019-12-16,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
12,D,2019-12-18 18:00:44,2019-12-16,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,47.23,-10595,7132,-60%,-500351.0,,,,,RARX
13,D,2019-11-18 17:08:11,2019-11-15,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
14,D,2019-11-18 17:08:11,2019-11-15,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,46.66,-10595,7132,-60%,-494319.0,,,,,RARX
15,D,2019-11-18 17:07:41,2019-11-14,RARX,Read Simon,Chief Scientific Officer,M - OptEx,2.87,10000,6234,-266%,28700.0,,,,,RARX
16,D,2019-11-18 17:07:41,2019-11-14,RARX,Read Simon,Chief Scientific Officer,S - Sale+OE,46.68,-10000,6234,-62%,-466808.0,,,,,RARX
17,,2019-10-17 20:11:09,2019-10-17,RARX,Ricardo Alonso,See Remarks,S - Sale,46.7,-2285,6858,-25%,-106710.0,,,,,RARX
18,D,2019-10-17 19:00:40,2019-10-16,RARX,Read Simon,Chief Scientific Officer,M - OptEx,2.87,10000,6234,-266%,28700.0,,,,,RARX
19,D,2019-10-17 19:00:40,2019-10-16,RARX,Read Simon,Chief Scientific Officer,S - Sale+OE,46.87,-10000,6234,-62%,-468726.0,,,,,RARX
20,D,2019-10-17 19:00:27,2019-10-15,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
21,D,2019-10-17 19:00:27,2019-10-15,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,46.89,-10595,7132,-60%,-496769.0,,,,,RARX
22,D,2019-09-16 18:44:08,2019-09-16,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
23,D,2019-09-16 18:44:08,2019-09-16,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,25.26,-10595,7132,-60%,-267675.0,,,,,RARX
24,D,2019-09-16 18:43:38,2019-09-12,RARX,Read Simon,Chief Scientific Officer,M - OptEx,2.87,10000,6234,-266%,28700.0,,,,,RARX
25,D,2019-09-16 18:43:38,2019-09-12,RARX,Read Simon,Chief Scientific Officer,S - Sale+OE,25.41,-10000,6234,-62%,-254050.0,,,,,RARX
26,D,2019-08-27 18:01:34,2019-08-23,RARX,Read Simon,Chief Scientific Officer,M - OptEx,2.87,10000,6234,-266%,28700.0,,,,,RARX
27,D,2019-08-27 18:01:34,2019-08-23,RARX,Read Simon,Chief Scientific Officer,S - Sale+OE,27.77,-10000,6234,-62%,-277703.0,,,,,RARX
28,D,2019-08-27 18:01:19,2019-08-23,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
29,D,2019-08-27 18:01:19,2019-08-23,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,27.77,-10595,7132,-60%,-294226.0,,,,,RARX
30,,2019-08-27 18:00:49,2019-08-23,RARX,Ricardo Alonso,See Remarks,S - Sale,27.89,-2285,9143,-20%,-63740.0,,,,,RARX
31,D,2019-07-18 19:04:22,2019-07-17,RARX,Read Simon,Chief Scientific Officer,M - OptEx,2.87,10000,6234,-266%,28700.0,,,,,RARX
32,D,2019-07-18 19:04:22,2019-07-17,RARX,Read Simon,Chief Scientific Officer,S - Sale+OE,32.95,-10000,6234,-62%,-329479.0,,,,,RARX
33,D,2019-07-16 19:15:18,2019-07-15,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
34,D,2019-07-16 19:15:18,2019-07-15,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,33.1,-10595,7132,-60%,-350647.0,,,,,RARX
35,,2019-06-25 16:16:37,2019-06-21,RARX,Ricardo Alonso,See Remarks,S - Sale,23.72,-2857,11428,-20%,-67782.0,,,,,RARX
36,D,2019-06-19 21:03:43,2019-06-18,RARX,Read Simon,Chief Scientific Officer,M - OptEx,2.87,10000,6234,-266%,28700.0,,,,,RARX
37,D,2019-06-19 21:03:43,2019-06-18,RARX,Read Simon,Chief Scientific Officer,S - Sale+OE,22.25,-10000,6234,-62%,-222467.0,,,,,RARX
38,D,2019-06-19 21:03:13,2019-06-17,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,5.6,10595,7132,-306%,59332.0,,,,,RARX
39,D,2019-06-19 21:03:13,2019-06-17,RARX,Farzaneh-Far Ramin,Chief Medical Officer,S - Sale+OE,21.84,-10595,7132,-60%,-231384.0,,,,,RARX
40,D,2019-04-18 17:55:16,2019-04-16,RARX,King John C,Chief Commercial Officer,F - Tax,21.93,-4506,10823,-29%,-98817.0,,,,,RARX
41,D,2019-04-18 17:55:16,2019-04-16,RARX,King John C,Chief Commercial Officer,M - OptEx,0.0,15329,10823,-340%,0.0,,,,,RARX
42,D,2019-02-05 19:39:45,2019-02-01,RARX,Lubner David Charles,"Exec VP, CFO",F - Tax,21.0,-3291,7126,-32%,-69111.0,,,,,RARX
43,D,2019-02-05 19:39:45,2019-02-01,RARX,Lubner David Charles,"Exec VP, CFO",M - OptEx,0.0,10417,7126,-317%,0.0,,,,,RARX
44,D,2019-02-05 19:39:00,2019-02-01,RARX,Read Simon,Chief Scientific Officer,F - Tax,21.0,-2933,6234,-32%,-61593.0,,,,,RARX
45,D,2019-02-05 19:39:00,2019-02-01,RARX,Read Simon,Chief Scientific Officer,M - OptEx,0.0,9167,6234,-313%,0.0,,,,,RARX
46,D,2019-02-05 19:38:45,2019-02-01,RARX,Farzaneh-Far Ramin,Chief Medical Officer,F - Tax,21.0,-3285,7132,-32%,-68985.0,,,,,RARX
47,D,2019-02-05 19:38:45,2019-02-01,RARX,Farzaneh-Far Ramin,Chief Medical Officer,M - OptEx,0.0,10417,7132,-317%,0.0,,,,,RARX
48,D,2019-02-05 19:38:16,2019-02-01,RARX,Treco Douglas A,"Pres, CEO",F - Tax,21.0,-6327,218799,-3%,-132867.0,,,,,RARX
49,D,2019-02-05 19:38:16,2019-02-01,RARX,Treco Douglas A,"Pres, CEO",M - OptEx,0.0,20834,218799,+11%,0.0,,,,,RARX
50,,2018-12-14 18:22:04,2018-12-14,RARX,New Enterprise Associates 13 LP,10%,P - Purchase,15.5,645161,6135234,+12%,9999996.0,,,,,RARX
51,,2018-12-14 18:17:56,2018-12-12,RARX,"Ra Capital Management, LLC","Dir, 10%",P - Purchase,15.5,1006452,4858260,+26%,15600006.0,,,,,RARX
52,,2018-12-14 18:14:24,2018-12-14,RARX,Shah Rajeev M.,"Dir, 10%",P - Purchase,15.5,1006452,4858260,+26%,15600006.0,,,,,RARX
53,,2018-02-21 16:19:25,2018-02-16,RARX,New Enterprise Associates 13 LP,10%,P - Purchase,6.0,2000000,5490073,+57%,12000000.0,,,,,RARX
54,,2018-02-16 16:42:56,2018-02-14,RARX,Shah Rajeev M.,"Dir, 10%",P - Purchase,6.0,2500000,3851808,+185%,15000000.0,,,,,RARX
55,,2018-02-16 16:42:52,2018-02-14,RARX,"Ra Capital Management, LLC","Dir, 10%",P - Purchase,6.0,2500000,3851808,+185%,15000000.0,,,,,RARX
56,M,2017-06-20 16:41:26,2017-06-16,RARX,Novartis Bioventures Ltd,10%,S - Sale,21.29,-56420,2251457,-2%,-1201106.0,,,,,RARX
57,,2017-06-12 16:12:39,2017-06-08,RARX,Novartis Bioventures Ltd,10%,S - Sale,22.0,-700,2307877,0%,-15400.0,,,,,RARX
58,M,2017-06-08 16:33:17,2017-06-06,RARX,Novartis Bioventures Ltd,10%,S - Sale,22.63,-12114,2308577,-1%,-274160.0,,,,,RARX
59,M,2017-06-06 16:27:13,2017-06-02,RARX,Novartis Bioventures Ltd,10%,S - Sale,23.38,-19647,2320691,-1%,-459437.0,,,,,RARX
60,M,2017-06-02 16:25:05,2017-05-31,RARX,Novartis Bioventures Ltd,10%,S - Sale,23.93,-46261,2340338,-2%,-1107073.0,,,,,RARX
61,M,2017-05-30 16:29:46,2017-05-25,RARX,Novartis Bioventures Ltd,10%,S - Sale,25.14,-5353,2386599,0%,-134592.0,,,,,RARX
62,,2017-05-25 16:57:17,2017-05-24,RARX,Novartis Bioventures Ltd,10%,S - Sale,25.01,-17451,2391952,-1%,-436364.0,,,,,RARX
63,,2017-05-22 18:50:53,2017-05-18,RARX,Novartis Bioventures Ltd,10%,S - Sale,25.5,-9019,2409403,0%,-229964.0,,,,,RARX
64,M,2017-05-18 16:36:50,2017-05-16,RARX,Novartis Bioventures Ltd,10%,S - Sale,25.9,-42615,2418422,-2%,-1103626.0,,,,,RARX
65,M,2017-05-02 17:22:17,2017-02-22,RARX,Novartis Bioventures Ltd,10%,S - Sale,20.96,-84615,2461037,-3%,-1773164.0,0.0,-2.0,,,RARX
66,D,2016-11-02 16:54:37,2016-10-31,RARX,Novo A/s,10%,C - Converted deriv,0.0,1785408,2031562,-47%,0.0,0.0,2.0,1.0,76.0,RARX
67,D,2016-11-02 16:54:37,2016-10-31,RARX,Novo A/s,10%,P - Purchase,13.0,246154,2031562,+14%,3200002.0,0.0,2.0,1.0,76.0,RARX
68,D,2016-10-31 20:46:44,2016-10-31,RARX,Shah Rajeev M.,Dir,C - Converted deriv,0.0,1190270,1968454,-38%,0.0,1.0,-1.0,1.0,78.0,RARX
69,D,2016-10-31 20:46:44,2016-10-31,RARX,Shah Rajeev M.,Dir,P - Purchase,13.0,161538,1968454,+9%,2099994.0,1.0,-1.0,1.0,78.0,RARX
70,D,2016-10-31 19:41:34,2016-10-31,RARX,"Ra Capital Management, LLC",Dir,C - Converted deriv,0.0,1190270,2542078,-32%,0.0,1.0,-1.0,1.0,78.0,RARX
71,D,2016-10-31 19:41:34,2016-10-31,RARX,"Ra Capital Management, LLC",Dir,P - Purchase,13.0,161538,2542078,+7%,2099994.0,1.0,-1.0,1.0,78.0,RARX
72,D,2016-10-31 16:52:27,2016-10-31,RARX,Weller Harry R,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
73,D,2016-10-31 16:52:27,2016-10-31,RARX,Weller Harry R,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
74,D,2016-10-31 16:52:27,2016-10-31,RARX,Weller Harry R,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
75,D,2016-10-31 16:52:27,2016-10-31,RARX,Weller Harry R,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
76,D,2016-10-31 16:51:59,2016-10-31,RARX,Morgenthaler Venture Partners IX LP,10%,C - Converted deriv,0.0,2402487,2745846,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
77,D,2016-10-31 16:51:59,2016-10-31,RARX,Morgenthaler Venture Partners IX LP,10%,P - Purchase,13.0,263538,2745846,+11%,3425994.0,1.0,-1.0,1.0,78.0,RARX
78,D,2016-10-31 16:51:59,2016-10-31,RARX,Morgenthaler Venture Partners IX LP,10%,S - Sale+OE,13.0,-340,2745846,0%,-4420.0,1.0,-1.0,1.0,78.0,RARX
79,D,2016-10-31 16:51:59,2016-10-31,RARX,Morgenthaler Venture Partners IX LP,10%,X - OptEx,0.07,63019,2745846,-2%,4411.0,1.0,-1.0,1.0,78.0,RARX
80,D,2016-10-31 16:51:54,2016-10-31,RARX,Viswanathan Ravi,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
81,D,2016-10-31 16:51:54,2016-10-31,RARX,Viswanathan Ravi,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
82,D,2016-10-31 16:51:54,2016-10-31,RARX,Viswanathan Ravi,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
83,D,2016-10-31 16:51:54,2016-10-31,RARX,Viswanathan Ravi,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
84,D,2016-10-31 16:51:28,2016-10-31,RARX,Sandell Scott D,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
85,D,2016-10-31 16:51:28,2016-10-31,RARX,Sandell Scott D,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
86,D,2016-10-31 16:51:28,2016-10-31,RARX,Sandell Scott D,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
87,D,2016-10-31 16:51:28,2016-10-31,RARX,Sandell Scott D,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
88,D,2016-10-31 16:51:14,2016-10-31,RARX,Lettmann Jason,Dir,C - Converted deriv,0.0,3592759,4066503,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
89,D,2016-10-31 16:51:14,2016-10-31,RARX,Lettmann Jason,Dir,P - Purchase,13.0,393923,4066503,+11%,5120999.0,1.0,-1.0,1.0,78.0,RARX
90,D,2016-10-31 16:51:14,2016-10-31,RARX,Lettmann Jason,Dir,S - Sale+OE,13.0,-340,4066503,0%,-4420.0,1.0,-1.0,1.0,78.0,RARX
91,D,2016-10-31 16:51:14,2016-10-31,RARX,Lettmann Jason,Dir,X - OptEx,0.07,63019,4066503,-2%,4411.0,1.0,-1.0,1.0,78.0,RARX
92,D,2016-10-31 16:51:01,2016-10-31,RARX,Mott David M,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
93,D,2016-10-31 16:51:01,2016-10-31,RARX,Mott David M,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
94,D,2016-10-31 16:51:01,2016-10-31,RARX,Mott David M,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
95,D,2016-10-31 16:51:01,2016-10-31,RARX,Mott David M,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
96,D,2016-10-31 16:50:35,2016-10-31,RARX,Kolluri Krishna Kittu,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
97,D,2016-10-31 16:50:35,2016-10-31,RARX,Kolluri Krishna Kittu,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
98,D,2016-10-31 16:50:35,2016-10-31,RARX,Kolluri Krishna Kittu,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
99,D,2016-10-31 16:50:35,2016-10-31,RARX,Kolluri Krishna Kittu,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
100,D,2016-10-31 16:50:29,2016-10-31,RARX,Novartis Bioventures Ltd,10%,C - Converted deriv,0.0,2398462,2545652,-49%,0.0,1.0,-1.0,1.0,78.0,RARX
101,D,2016-10-31 16:50:29,2016-10-31,RARX,Novartis Bioventures Ltd,10%,P - Purchase,13.0,84615,2545652,+3%,1099995.0,1.0,-1.0,1.0,78.0,RARX
102,D,2016-10-31 16:50:29,2016-10-31,RARX,Novartis Bioventures Ltd,10%,S - Sale+OE,13.0,-339,2545652,0%,-4407.0,1.0,-1.0,1.0,78.0,RARX
103,D,2016-10-31 16:50:29,2016-10-31,RARX,Novartis Bioventures Ltd,10%,X - OptEx,0.07,62914,2545652,-2%,4404.0,1.0,-1.0,1.0,78.0,RARX
104,D,2016-10-31 16:50:05,2016-10-31,RARX,Kerins Patrick J,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
105,D,2016-10-31 16:50:05,2016-10-31,RARX,Kerins Patrick J,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
106,D,2016-10-31 16:50:05,2016-10-31,RARX,Kerins Patrick J,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
107,D,2016-10-31 16:50:05,2016-10-31,RARX,Kerins Patrick J,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
108,D,2016-10-31 16:49:39,2016-10-31,RARX,Baskett Forest,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
109,D,2016-10-31 16:49:39,2016-10-31,RARX,Baskett Forest,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
110,D,2016-10-31 16:49:39,2016-10-31,RARX,Baskett Forest,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
111,D,2016-10-31 16:49:39,2016-10-31,RARX,Baskett Forest,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
112,D,2016-10-31 16:49:13,2016-10-31,RARX,Barris Peter J,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
113,D,2016-10-31 16:49:13,2016-10-31,RARX,Barris Peter J,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
114,D,2016-10-31 16:49:13,2016-10-31,RARX,Barris Peter J,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
115,D,2016-10-31 16:49:13,2016-10-31,RARX,Barris Peter J,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
116,D,2016-10-31 16:48:46,2016-10-31,RARX,Barrett M James,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
117,D,2016-10-31 16:48:46,2016-10-31,RARX,Barrett M James,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
118,D,2016-10-31 16:48:46,2016-10-31,RARX,Barrett M James,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
119,D,2016-10-31 16:48:46,2016-10-31,RARX,Barrett M James,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
120,D,2016-10-31 16:48:16,2016-10-31,RARX,New Enterprise Associates 13 LP,10%,C - Converted deriv,0.0,3071388,3490073,-47%,0.0,1.0,-1.0,1.0,78.0,RARX
121,D,2016-10-31 16:48:16,2016-10-31,RARX,New Enterprise Associates 13 LP,10%,P - Purchase,13.0,338462,3490073,+11%,4400006.0,1.0,-1.0,1.0,78.0,RARX
122,D,2016-10-31 16:48:16,2016-10-31,RARX,New Enterprise Associates 13 LP,10%,S - Sale+OE,13.0,-435,3490073,0%,-5655.0,1.0,-1.0,1.0,78.0,RARX
123,D,2016-10-31 16:48:16,2016-10-31,RARX,New Enterprise Associates 13 LP,10%,X - OptEx,0.07,80658,3490073,-2%,5646.0,1.0,-1.0,1.0,78.0,RARX
